Detalles de la búsqueda
1.
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.
Proc Natl Acad Sci U S A
; 108(31): 12669-74, 2011 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-21768335
2.
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity.
Blood
; 115(22): 4393-402, 2010 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-20194898
3.
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity.
Clin Cancer Res
; 27(14): 4036-4053, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33771854
4.
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody.
Nat Commun
; 11(1): 3196, 2020 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32581215
5.
The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment.
Cancer Res
; 80(13): 2903-2913, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32409308
6.
P329G-CAR-J: a novel Jurkat-NFAT-based CAR-T reporter system recognizing the P329G Fc mutation.
Protein Eng Des Sel
; 32(5): 207-218, 2019 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31504896
7.
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy.
Sci Transl Med
; 11(496)2019 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31189721
8.
Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineering.
Cancer Res
; 65(17): 7934-41, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16140965
9.
Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines.
Oncoimmunology
; 6(3): e1277306, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28405498
10.
RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis.
Mol Cancer Ther
; 15(5): 946-57, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27037412
11.
The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms.
J Biol Chem
; 281(8): 5032-6, 2006 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-16330541
12.
Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II.
Biotechnol Bioeng
; 93(5): 851-61, 2006 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-16435400
13.
Genetic engineering of an industrial strain of Saccharopolyspora erythraea for stable expression of the Vitreoscilla haemoglobin gene (vhb).
Microbiology (Reading)
; 144 ( Pt 9): 2441-2448, 1998 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-9782491
Resultados
1 -
13
de 13
1
Próxima >
>>